What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2024 Data d'inici Mon, 17 Jun 2024 - 12:00 Data de tancament Mon, 1 Jul 2024 - 12:00 Grup de recerca Stroke research Descripció Data Entry/Study Coordinator- Stroke Research_20240204 Codi 2024-204 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0204//2024_0204_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 17 Jun 2024 - 12:00 Data de tancament Mon, 1 Jul 2024 - 12:00 Grup de recerca Clinical and Translational Bioinformatics Descripció Postdoctoral Position in Pathogenicity Prediction Models for Missense Mutations Clinical and Translational Bioinformatics Group Codi 2024-205 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0205//2024_0205_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 17 Jun 2024 - 12:00 Data de tancament Mon, 1 Jul 2024 - 12:00 Descripció Clinical trials pharmacy technician - Pharmacy Unit_20240206 Codi 2024-206 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0206//2024_0206_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 14 Jun 2024 - 12:00 Data de tancament Fri, 28 Jun 2024 - 12:00 Grup de recerca Stroke research Descripció Clinical Researcher - Stroke Research Group_20240203 Codi 2024-203 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0203//2024_0203_001.pdf Reclutant Inactiu Year 2024 Data d'inici Thu, 13 Jun 2024 - 12:00 Data de tancament Thu, 27 Jun 2024 - 12:00 Grup de recerca Nephrology and kidney transplantation Descripció Postdoctoral Researcher Nephrology and Transplantation Research Group Codi 2024-202 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0202//2024_0202_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 7 Jun 2024 - 12:00 Data de tancament Fri, 21 Jun 2024 - 12:00 Descripció IT Project Manager_20240196 Codi 2024-196 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0196//2024_0196_001.pdf Reclutant Inactiu Year 2024 Data d'inici Wed, 12 Jun 2024 - 12:00 Data de tancament Wed, 26 Jun 2024 - 12:00 Descripció Technical specialist in flow cytometry_20240200 Codi 2024-200 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0200//2024_0200_001.pdf Reclutant Inactiu Year 2024 Data d'inici Wed, 12 Jun 2024 - 12:00 Data de tancament Wed, 26 Jun 2024 - 12:00 Descripció Health & Safety Specialist_20240201 Codi 2024-201 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0201//2024_0201_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 11 Jun 2024 - 12:00 Data de tancament Tue, 25 Jun 2024 - 12:00 Grup de recerca Liver Diseases Descripció Postdoctoral Researcher_Advanced Chronic Liver Disease Laboratory_20240198 Codi 2024-198 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0198//2024_0198_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 11 Jun 2024 - 12:00 Data de tancament Tue, 25 Jun 2024 - 12:00 Grup de recerca Liver Diseases Descripció Research nurse_Liver, Metabolism and Infection (LivMI) team_20240199 Codi 2024-199 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0199//2024_0199_001.pdf Reclutant Inactiu Evaluación de la eficacia y toxicidad del us de gammaglobulina intravenosa en el tratamiento de infecciones en pacientes con hipogammaglobulinemia igg post-trasplante de órgano sólido. Contact Protocol code: FIBHGM-ECNC001-2012 EudraCT code: 2012-001327-12 Principal investigator: Bravo Masgoret, Carles Research group: Pneumologia Service: Pneumologia Phase: Fase II Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Tolerabilidad y seguridad a largo plazo de la infusión de inmunoglobulina (humana) al 10 % con hialuronidasa recombinante humana (YQVIA/HyQvia) para el tratamiento de la polirradiculoneuropatía desmielinizante inflamatoria crónica (PDIC) Contact Protocol code: 161505 EudraCT code: 2016-000374-37 Principal investigator: Salvadó Figueras, Maria Research group: Sistema nerviós perifèric Service: Neurologia Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase I/II de inotuzumab ozogamicina (InO) en monoterapia y en combinación con quimio para el tto de la leucemia linfoblástica aguda positiva para CD22 recidivante o refractaria en sujetos pediátricos Contact Protocol code: ITCC-059 EudraCT code: 2016-000227-71 Principal investigator: Díaz de Heredia Rubio, Maria Cristina Research group: Càncer i malalties hematològiques infantils Service: Oncohematologia Pediàtrica Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio fase 1, multicéntrico, abierto, de CC-97540 - BMS 986353, linfocitos T con receptor de antígeno quimérico CAR NEX-T dirigidos a CD19, en participantes con lupus eritematoso sistémico LES severo y refractarioCD19, en participantes con lupus eritematoso sistémico (LES) severo y refractario Contact Protocol code: CA061-1001 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Cortes Hernandez, Josefina Research group: Reumatologia Service: Reumatologia Phase: Phase I Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC,RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPYVERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICALCONTROL IN HIGH-RISK GOLD B PATIENTS (B+) Contact Protocol code: ANTES B EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Miravitlles Fernández, Marc Research group: Pneumology Service: Pneumology Phase: Fase IV Recruiting: Closed Status: Tancat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Comparison of treatment completion rates with three short-course rifamycin-based regimens (three months of daily isoniazid plus rifampicin [3HR], three months of once-weekly isoniazid plus rifapentine [3HP], and four months of daily rifampicin [4R]) for treatment of latent tuberculosis infection in patients with end-stage kidney disease: A randomised controlled clinical trial] Contact Protocol code: PI21/004444 EudraCT code: 2021-003995-15 Pathology: Diseases of the respiratory system Principal investigator: De Souza Galvao, Maria Luiza Research group: Pneumology Service: Pneumology Phase: Phase IV Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de extensión, aleatorizado, doble ciego y controlado con placebo para evaluar la seguridad y la tolerabilidad de ianalumab a largo plazo en pacientes con lupus eritematoso sistémico (extensión de SIRIUS-SLE). Contact Protocol code: CVAY736F12301E1 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Cortes Hernandez, Josefina Research group: Rheumatology Service: Rheumatology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo de fase 3, doble ciego, aleatorizado y comparativo con placebo para evaluar la eficacia y la seguridad de AR1001 durante 52 semanas en participantes con enfermedad de Alzheimer incipiente Contact Protocol code: AR1001-ADP3-US01 EudraCT code: No aplica Pathology: Malalties del sistema nerviós Principal investigator: Delgado Martínez, Maria Pilar Research group: Malalties neurovasculars Service: Neurology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, aleatorizado, doble ciego, controlado con placebo, multicéntrico para evaluar la eficacia y la seguridad del deplecionador de amiloide ALXN2220 en participantes adultos con amiloidosis cardiaca por transtiretina (ATTR-CM) Contact Protocol code: ALXN2220-ATTRCM-301 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Martínez Valle, Fernando Research group: Malalties sistèmiques Service: Medicina Interna Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3 multicéntrico para evaluar la eficacia,seguridad y farmacocinética de la inducción de upadacitinib en régimen abierto,aleatorizado, mantenimiento doble ciego y extensión abierta a largo plazo ensujetos pediátricos con colitis ulcerosa activa de moderada a severa y conrespuesta insuficiente, intolerancia o contraindicaciones médicas al tratamientocon corticosteroides, inmunosupresores o terapias biológicas. Contact Protocol code: M14-658 EudraCT code: No aplica Pathology: Malalties del sistema digestiu Principal investigator: Segarra Canton, Oscar Research group: Recerca en microbioma Service: Pediatria General i Especialitats Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 1427 Page 1428 Current page 1429 Page 1430 Page 1431 … Next page › Last page »
Year 2024 Data d'inici Mon, 17 Jun 2024 - 12:00 Data de tancament Mon, 1 Jul 2024 - 12:00 Grup de recerca Stroke research Descripció Data Entry/Study Coordinator- Stroke Research_20240204 Codi 2024-204 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0204//2024_0204_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 17 Jun 2024 - 12:00 Data de tancament Mon, 1 Jul 2024 - 12:00 Grup de recerca Clinical and Translational Bioinformatics Descripció Postdoctoral Position in Pathogenicity Prediction Models for Missense Mutations Clinical and Translational Bioinformatics Group Codi 2024-205 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0205//2024_0205_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 17 Jun 2024 - 12:00 Data de tancament Mon, 1 Jul 2024 - 12:00 Descripció Clinical trials pharmacy technician - Pharmacy Unit_20240206 Codi 2024-206 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0206//2024_0206_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 14 Jun 2024 - 12:00 Data de tancament Fri, 28 Jun 2024 - 12:00 Grup de recerca Stroke research Descripció Clinical Researcher - Stroke Research Group_20240203 Codi 2024-203 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0203//2024_0203_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Thu, 13 Jun 2024 - 12:00 Data de tancament Thu, 27 Jun 2024 - 12:00 Grup de recerca Nephrology and kidney transplantation Descripció Postdoctoral Researcher Nephrology and Transplantation Research Group Codi 2024-202 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0202//2024_0202_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 7 Jun 2024 - 12:00 Data de tancament Fri, 21 Jun 2024 - 12:00 Descripció IT Project Manager_20240196 Codi 2024-196 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0196//2024_0196_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Wed, 12 Jun 2024 - 12:00 Data de tancament Wed, 26 Jun 2024 - 12:00 Descripció Technical specialist in flow cytometry_20240200 Codi 2024-200 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0200//2024_0200_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Wed, 12 Jun 2024 - 12:00 Data de tancament Wed, 26 Jun 2024 - 12:00 Descripció Health & Safety Specialist_20240201 Codi 2024-201 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0201//2024_0201_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 11 Jun 2024 - 12:00 Data de tancament Tue, 25 Jun 2024 - 12:00 Grup de recerca Liver Diseases Descripció Postdoctoral Researcher_Advanced Chronic Liver Disease Laboratory_20240198 Codi 2024-198 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0198//2024_0198_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 11 Jun 2024 - 12:00 Data de tancament Tue, 25 Jun 2024 - 12:00 Grup de recerca Liver Diseases Descripció Research nurse_Liver, Metabolism and Infection (LivMI) team_20240199 Codi 2024-199 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0199//2024_0199_001.pdf Reclutant Inactiu
